MetLife Investment Advisors »

Tarsus Pharmaceuticals shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Tarsus Pharmaceuticals (TARS) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Tarsus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Tarsus Pharmaceuticals held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tarsus Pharmaceuticals by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $315k 16k 20.25
2023-09-30 $227k 13k 17.77
2023-06-30 $231k 13k 18.07
2023-03-31 $134k 11k 12.57
2022-12-31 $157k 11k 14.66
2022-09-30 $183k 11k 17.14
2022-06-30 $156k 11k 14.62
2020-12-31 $134k 3.3k 41.33